Q2867071 (Q2867071): Difference between revisions
Jump to navigation
Jump to search
(Created a new Item: import item from Portugal) |
(Changed label, description and/or aliases in en: Setting new description) |
||
| description / en | description / en | ||
Project in Portugal | Project Q2867071 in Portugal | ||
Revision as of 22:53, 5 July 2021
Project Q2867071 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project Q2867071 in Portugal |
Statements
25,000.0 Euro
0 references
76.0 percent
0 references
1 April 2020
0 references
1 April 2023
0 references
BSIM THERAPEUTICS, S.A.
0 references
O projeto TERAPI4 visa a proteção dos direitos de Propriedade Intelectual de uma nova classe de agentes terapêuticos contra doenças amiloides raras de transtirretina. Estes novos compostos são pequenas moléculas pertencentes à série química NT60 desenvolvida pela BSIM Therapeutics. (Portuguese)
0 references
Coimbra
0 references
Identifiers
CENTRO-01-0247-FEDER-046897
0 references